Home/Filings/4/0001415889-25-023974
4//SEC Filing

WILSON TROY EDWARD 4

Accession 0001415889-25-023974

CIK 0001422143other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 4:28 PM ET

Size

6.6 KB

Accession

0001415889-25-023974

Insider Transaction Report

Form 4
Period: 2025-09-08
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2025-09-08$8.20/sh+50,000$410,145100,968 total
Holdings
  • Common Stock

    (indirect: By Trust)
    279,194
  • Common Stock

    (indirect: By Trust)
    300,000
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1
  • filerCIK 0001589597

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:28 PM ET
Size
6.6 KB